Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
Gut
Published October 1, 2026
Clinical impact of prospective circulating tumour DNA testing for minimal residual disease in col...
October 2, 2026
Medspoke
Medspoke
Leukemia & Lymphoma
Published October 1, 2026
00:00
--:--
Venetoclax consolidation deepens response and enables measurable residual disease-guided finite t...
October 2, 2026
Share
Venetoclax consolidation deepens response and enables measurable residual disease-guided finite therapy in BTK inhibitor-treated chronic lymphocytic leukemia.
https://www.medspoke.co/channel_journal?id=794&tap_id=14889
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
Journal of the Endocrine Society
Published September 23, 2026
The effect of time-restricted eating accompanied by weight loss on thyroid function in adults wit...
October 2, 2026
Why are you reporting this TALK?
